Atrial Fibrillation (AFib) clinical trials in Louisiana
11 active Atrial Fibrillation (AFib) trials with a site in Louisiana. Describe your situation to see which ones look like a fit.
- The Fourth Left Atrial Appendage Occlusion Study
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
- Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- The CONFORM Pivotal Trial
- Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study
- Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- The CoAGulation Biomarkers and Atrial Fibrillation (COAG-AF) Pilot Study
- Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.